Uningwei announced that the company previously co-funded the establishment of the Shanghai Guohong Medical Innovation and Intelligent Venture Capital Partnership with Shanghai Changjiang Guohong Investment Management Co., Ltd., and that the fund has completed industrial and commercial registration procedures and obtained a business license. The fund's investment amount is 150 million yuan. The executive partner is Shanghai Changjiang Guohong Investment Management Co., Ltd., which was established on October 30, 2026, and its business scope is venture capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.